Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 8 min read

This article was created with AI assistance.

Pheochromocytoma Crisis for ICU Nurses 2026 — The Catecholamine Storm

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

A pheochromocytoma is a tumor of the adrenal medulla that manufactures and dumps catecholamines — adrenaline and noradrenaline — on its own schedule. When it discharges in force, the patient is hit by a chemical storm: pounding headache, drenching sweat, a hammering heart, and a blood pressure that can rocket past 220 systolic in minutes and then collapse just as suddenly. It is rare, it is dangerous, and it contains one of the most important "do not do this" rules in all of critical care. This guide covers what the crisis looks like, the alpha-before-beta rule that can save a life, and how to nurse the wild swings around surgery.

The short version: A pheochromocytoma crisis is a flood of catecholamines that drives severe, swinging hypertension with the classic triad of headache, sweating, and palpitations. The cardinal rule: never give a beta-blocker before alpha-blockade is established. Blocking beta alone leaves alpha-driven vasoconstriction unopposed and can send the pressure even higher, into pulmonary edema and stroke. Treatment leans on alpha-blockade first (e.g., phenoxybenzamine or phentolamine), then careful volume repletion, and beta-blockade only afterward for the tachyarrhythmia. Surgery is the cure, but the peri-operative swings are the most dangerous hours.

What the storm does to the body

Catecholamines are the body's fight-or-flight chemicals, and a pheochromocytoma releases them without any of the normal control. The alpha-adrenergic effect clamps blood vessels shut, driving the blood pressure sky-high; the beta effect whips the heart faster and harder, causing palpitations, arrhythmias, and, over time, a stress cardiomyopathy that can look like acute heart failure. Because the release is episodic, the hallmark is a patient whose vitals lurch: paroxysms of crushing hypertension, tachycardia, sweating, pallor, tremor, anxiety, and headache, sometimes triggered by anesthesia induction, tumor manipulation, or certain drugs, then swinging toward hypotension as the surge fades or as the chronically constricted, volume-depleted circulation is unmasked. That volatility — not just the high numbers — is what makes the ICU course treacherous.

The rule that outranks everything: alpha before beta

If you remember one thing about pheochromocytoma, make it this: do not give a beta-blocker until the patient is alpha-blocked. Here is the physiology. Catecholamines are hitting both alpha receptors (which constrict vessels) and beta-2 receptors (which cause some vasodilation, partly offsetting the constriction). If you block beta first, you remove that offsetting vasodilation and the beta-driven increase in cardiac output, leaving the alpha-mediated vasoconstriction completely unopposed. The result is a paradoxical, sometimes catastrophic, further rise in blood pressure — hypertensive crisis, pulmonary edema, myocardial injury, or stroke. The safe sequence is alpha-blockade established first (classically phenoxybenzamine over days before elective surgery, or IV phentolamine for acute crisis), then a beta-blocker added afterward to control the reflex or residual tachycardia.

An unlabeled beta-blocker order on a pheochromocytoma patient is a stop-and-clarify moment. If a patient with known or suspected pheochromocytoma has an order for a beta-blocker and you cannot confirm adequate alpha-blockade is already on board, do not administer it — verify with the prescriber first. This is one of the clearest examples in ICU nursing where the sequence of two drugs is itself a patient-safety issue.

Managing the acute crisis

In an active hypertensive crisis, the team reaches for rapidly titratable IV agents that address the alpha effect and the pressure directly. Common choices include IV phentolamine (a direct alpha-antagonist), and titratable vasodilators such as nicardipine, nitroprusside, or a magnesium infusion, chosen for their smooth, minute-to-minute controllability. As the nurse, you are running these on tight titration against an arterial line, because the pressure can move fast in both directions. Beta-blockade — often esmolol for its short half-life — is layered in after alpha control to manage tachyarrhythmia. The other half of the job is anticipating the crash: these patients are often profoundly volume-depleted from chronic vasoconstriction, so once the vessels relax the pressure can plummet, and volume repletion is part of the plan.

SituationPriorityNursing focus
Acute hypertensive paroxysmAlpha-antagonist / titratable vasodilatorArterial-line titration, watch for overshoot into hypotension
Tachyarrhythmia after alpha-blockadeShort-acting beta-blocker (e.g., esmolol)Confirm alpha-blockade is already established first
Pre-operative preparationDays of alpha-blockade + volume loadingTrack orthostatics, encourage salt/fluid per orders, monitor for reflex tachycardia
Post-tumor-removalAnticipate hypotension & hypoglycemiaCatecholamine source is gone; be ready with fluids/pressors and glucose checks

The surgical rollercoaster

Removing the adrenal tumor is the definitive cure, but the peri-operative window is when the physiology is most violent. During surgery, handling the tumor can squeeze out a bolus of catecholamines and spike the pressure; the moment the tumor's blood supply is clamped, the catecholamine tap shuts off abruptly and the patient can crash into hypotension, because their vessels were being held open by nothing and their volume was depleted. So the post-operative ICU nurse braces for the opposite problem from the one that brought the patient in: hypotension needing fluids and sometimes pressors, and hypoglycemia, because the sudden fall in catecholamines can unmask rebound insulin activity and drop the blood sugar. Frequent glucose checks and hemodynamic vigilance for the first day are standard.

Think of the whole course as three acts. Before surgery: alpha-blockade first, then volume, then beta if needed. During: expect spikes on tumor manipulation. After: expect the floor to drop out — hypotension and hypoglycemia once the catecholamine source is gone. Nursing that anticipates the next act rather than reacting to the current one is what keeps these patients safe.

The nursing bottom line

A pheochromocytoma crisis is a catecholamine storm that whipsaws the blood pressure and hammers the heart, announced by the triad of headache, sweating, and palpitations. The single most important rule is to establish alpha-blockade before ever giving a beta-blocker — reversing that order can trigger a lethal hypertensive crisis, so an unclarified beta-blocker order is a reason to stop and call. Manage the acute storm with titratable alpha-antagonists and vasodilators against an arterial line, add short-acting beta-blockade only afterward, and remember these patients are volume-depleted and will crash when the vessels finally relax. Then carry that anticipation into the operating room and beyond, where removing the tumor flips the danger to hypotension and hypoglycemia. Stay one act ahead of the physiology.

Related: Hypertensive emergency · Adrenal crisis · Thyroid storm

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.